Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationPeripheral Blood Stem Cell TransplantationMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMelphalanTransplantation, HomologousTransplantation ConditioningCombined Modality TherapyTreatment OutcomeRemission InductionStem CellsSalvage TherapyDisease-Free SurvivalEtoposideHodgkin DiseaseCyclophosphamideLymphoma, Non-HodgkinMyeloablative AgonistsRecurrenceCytarabineCarmustineSurvival RateHematopoietic Stem Cell MobilizationBone Marrow TransplantationGraft vs Host DiseaseThiotepaVincristineBone Marrow PurgingSurvival AnalysisHematologic NeoplasmsLymphoma, Mantle-CellWhole-Body IrradiationAmyloidosisRetrospective StudiesDisease ProgressionDoxorubicinHematopoietic Stem CellsPrognosisBusulfanBoronic AcidsDexamethasonePyrazinesGraft SurvivalFollow-Up StudiesAntibodies, Monoclonal, Murine-DerivedAntineoplastic Agents, AlkylatingLymphoma, FollicularAntigens, CD34AutograftsLymphoma, T-Cell, PeripheralLiver TransplantationThalidomideAntineoplastic AgentsIfosfamideTime FactorsInduction ChemotherapyMesenchymal Stem Cell TransplantationGranulocyte Colony-Stimulating FactorLeukapheresisPrednisoneLymphomaPodophyllotoxinLymphoma, Large B-Cell, DiffuseNeoplasm, ResidualTransplantation ChimeraMaintenance ChemotherapyTissue DonorsLeukemia, Myeloid, AcuteCord Blood Stem Cell TransplantationCell TransplantationKidney TransplantationLymphoma, B-CellEmbryonic Stem CellsEnteropathy-Associated T-Cell LymphomaMyelodysplastic SyndromesMitoxantroneIdarubicinLeukemia, Plasma CellNeoplasms, Second PrimaryInfusions, SpinalProspective StudiesCisplatinCarboplatinAdult Stem CellsBlood Component RemovalImmunosuppressive AgentsChemotherapy, AdjuvantNeoplasm Recurrence, LocalHistocompatibility TestingAntibodies, MonoclonalDrug Administration ScheduleFeasibility StudiesCell DifferentiationLeukemia, MyeloidFatal OutcomeKeratins, Type IIRisk FactorsLife Tables